GL1X · GenesisL1 explorer

Research workbench

Glycogen phosphorylase inhibitors

Analyse Glycogen phosphorylase inhibitors in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2ATI
Type
protein
Length
1,582 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycogen phosphorylase, liver form
EC
2.4.1.1
UniProt
P06737
Ligands
IHU, PLP, GLC
Pockets
20 · best druggability 0.85

Structure

x-ray diffraction · 1 distinct chain · 52% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BGlycogen phosphorylase, liver form (EC 2.4.1.1)protein79152% helix, 16% strandP06737

Ligands and binding sites

  • IHU · N-(2-chloro-4-fluorobenzoyl)-N'-(5-hydroxy-2-methoxyphenyl)urea · ligand · 2 copies · chains A, B
  • PLP · Pyridoxal-5'-phosphate · ligand · 2 copies · chains A, B
  • GLC · alpha-D-glucopyranose · sugar · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 9 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111380.850.8779empty
22500.840.9646GLC, PLP
32360.840.9647GLC, PLP
41190.760.9639empty
53070.710.8427IHU

Interfaces

1 interface between chains.

  • A–B · 2353 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 cofactor (pyridoxal phosphate Schiff base).

Compared structures

  • 2ATI · Glycogen Phosphorylase Inhibitors · the same entry in another collection · chain A against A, TM-score 1.00
  • P06737 · AlphaFold monomer V2.0 prediction for glycogen phosphorylase, liver form (P06737) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.